ReviewMolecular neurobiology2026
The Tale of the Guanosine Tract in Repeat Expansion Disorders.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Repeat expansion disorders (REDs) constitute a major class of neurological and neuromuscular pathologies that affect millions worldwide. Guanosine (G)-rich sequences are often implicated in these disorders due to their ability to adopt highly stable, non-canonical secondary structures that trigger genomic instability. These include but are not limited to conformations such as G-quadruplexes (G4s), hairpins and R-loops that can critically alter the cell's molecular events. Herein, we focused on how guanosine governs the formation of diverse secondary structures and discussed the array of G-rich tracts that are known to trigger various REDs. We pinpoint the key molecular mechanisms through which these G-tracts contribute to disease onset and progression. Emphasis has been laid on the interconnected nature of these mechanisms that ultimately converge and reinforce one another to drive various cellular dysfunctions. Targeting these shared molecular nodes through small-molecule disruptors, R-loop resolving approaches, antisense oligonucleotides (ASOs) and clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing holds significant translational potential across a multitude of REDs. Lastly, we highlight the potential of integrative multi-omics and structural approaches to understand the equilibrium orchestrated by cellular processes that ultimately dictates whether G-tracts function as genome regulators or evolve into pathological hotspots.
Indexed as
Identifiers
41774357What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.